Ensuring the protection of persons who participate in research, especially in clinical drug trials, and promoting the highest ethical standards for research involving humans is the responsibility of many actors who participate in international collaborative research.
The KFPE (The Commission for Research Partnership with Developing Countries) is dedicated to promoting research partnerships with developing and transition countries. In this way, it wishes to contribute to sustainable development.
Continuing education of healthcare professionals is a key element for the quality and efficiency of a health system. In developing countries, this activity is usually limited to capitals, and delocalized professionals do not have access to such opportunities, or to didactic material adapted to their needs.
The availability of quality and non-counterfeit drugs is an essential part of any health care delivery service. This session presented the audience with information related to the expansion of private-public partnerships (PPPs) for the development of safe drugs and of drugs for neglected diseases.
Health research has several crucial roles to play in ensuring that people everywhere have access to health.
The IFPMA Clinical Trials Portal www.ifpma.org/clinicaltrials is the first internet search engine to link to online information about on-going and completed clinical trials sponsored by research-based pharmaceutical companies worldwide.
Impressive strides have been made in biomedicine and it is on account of the results of health research that the people enjoy a longer life expectancy through use of products of research like the vaccines, drugs, diagnostics, better management of diseases and life threatening conditions.
The symposium on “Research and Access to Health: Ethical Concerns” has highlighted the fact that strong laws are a powerful tool to protect participants in experimental clinical trials.
Over the past decade, Latin America has evolved into a very dynamic area for conducting Clinical Research, particularly with regard to the development of new antimicrobials and vaccines. Between 1995 and 2000, the number of clinical trials executed in the region rose over a factor of ten.
Session Outline Parallel session PS10, Thursday, August 31 2006, 11:00-12:30 Chair(s): Peter Suter, Switzerland, Peter Saladin, Switzerland Social Accountability of Medical Schools in a Globalized World Kendall Ho, Continuing Professional Development & Knowledge Translation, University of British Columbia, Vancouver, Canada Troped Network: Bringing Together European Institutions for Higher Education in International Health Jean-Pierre Gervasoni, Unit for Cardiovascular Disease and […]